
If you hold a tokenized Cerebras share, the figure that matters most over the coming weeks is not a price target but a date. On September 16, 2026 at 10:00 UTC, which is midday in central Europe, a further 14.6 million shares in Cerebras Systems become freely sellable for the first time. That date appears in no press release. It sits in a table on page 190 of the IPO prospectus the company filed with the US Securities and Exchange Commission.
This article turns that table into a readable calendar and answers a question almost nobody is asking: what does the Cerebras lockup mean for tokenized stocks, meaning the wrappers CBRSB, CBRSX and CBRSON that trade on crypto platforms? The short answer first. The schedule governs the supply of real shares. It reaches the tokens only indirectly, through the price they track. Confuse the two and you will budget for a dilution that does not exist on the blockchain.
What the Cerebras lockup is and why it concerns holders of tokenized stocks
A lockup is a contractual undertaking by existing shareholders and employees, given to the underwriting banks, not to sell their holdings for a set period after the IPO. The purpose is to prevent an overhang of supply in the days after the first trading session, which would deter new investors. When a lockup expires, the number of shares that may be sold at all rises. The number of shares in issue does not change.
A tokenized stock is a claim against an issuer, recorded on a blockchain, that tracks the price of a real share. You are not buying a security and you do not become a shareholder. What you hold is a receivable against the house that issues the wrapper and deposits the underlying shares. That is where this subject connects to the crypto market: Cerebras has traded in four such wrappers since spring 2026, and their price follows the Nasdaq quote. Whatever changes supply in the equity market reaches you as a price move, without a single new token being created. Cryptoticker described the mechanics in detail when Binance launched its offering in June 2026.
Cerebras Systems is a US AI chipmaker based in Sunnyvale that builds data centre accelerators for artificial intelligence. Its distinguishing feature is the Wafer Scale Engine, a chip that occupies an entire semiconductor wafer rather than the usual fingernail-sized area. Those AI chips are the reason the company went public at all. The IPO took place in May 2026 and the stock trades on Nasdaq under the ticker CBRS. At an offer price of $185.00 per share, the prospectus shows gross proceeds of $5.55 billion for the base offering; after full exercise of the over-allotment option, the company cites $6.4 billion in its own quarterly release. Both figures are correct, and they refer to different scopes.
The release schedule from the IPO prospectus: every tranche through November 9, 2026
The prospectus dated May 13, 2026 contains a table headed "Earliest Date Available for Sale in the Public Market". For each step it lists a date and a maximum number of Class A shares. The wording that matters is "up to approximately": the table gives ceilings on what may be sold, not a forecast of what will be sold. That distinction carries the rest of this article.
All the fixed dates carry a time of 6:00 a.m. Eastern in the prospectus, which is 10:00 UTC in September and October and midday in Germany. The release therefore happens before US trading opens, not in the middle of the session.
The cross-check that makes the schedule reliable
The ten numbered tranches add up to 171.1 million shares. The prospectus itself cites exactly that total elsewhere, where it estimates the early releases: "an aggregate of up to approximately 171.1 million shares", of which up to 15.0 million come from the holdings of executive officers and directors. The table therefore balances on both sides, and that is why you can rely on this calendar.
The residual works out as well. After the offering, 215,110,345 shares are outstanding, or 219,610,345 on full exercise of the over-allotment. Subtract from the larger figure the 34.5 million freely tradable shares from the IPO and the 171.1 million early releases, and 14,010,345 shares remain for the final date. An independent issuance dataset lists exactly that number for November 9, 2026. Two sources that do not derive from one another arrive at the same remainder.
Why September 4 in the issuance dataset does not match the prospectus
Look the calendar up at an aggregator and you will find a tranche of 36.4 million shares for September 4, 2026. Against the prospectus that date cannot be right, and the reason lies in the clause itself. The 36.4 million hang on an event rather than on a calendar day, namely the "second trading day after the release of our results for the quarter ended June 30, 2026". Those results are long since out: according to its own filing with the SEC, Cerebras published them after the close on August 12, 2026. The second trading day after that was Friday, August 14, 2026.
The cross-check against the first quarter confirms the mechanism. The same dataset carries the 27.7 million for June 25, 2026, which is the second trading day after the Q1 release. For the second quarter, by contrast, it carries a date three weeks later than the results actually appeared. For you that means the tranche has already passed, and anyone building a plan around a 36.4 million share release in early September is planning for an event that took place in August.
That leaves 87.4 million shares from September 2 onwards, in five numbered steps, plus the unnumbered final date. Measured against the 215.1 million shares outstanding, the five steps together come to a good 40 percent.